Tissue specific expression of antibodies in chickens
AssigneeOrigen Therapeutics, Inc.
InventorsLei Zhu, Wen Zhou, Robert Etches
Life of this patent
Estimating the term…
Abstract
Transgenes encoding exogenous antibodies are stably integrated into donor cells and are present in the somatic tissue of chimeric birds. The transgenes encode exogenous antibodies and are preferably expressed in the oviduct for collection in the egg. Tissue specificity is provided by selecting the content of the transgene accordingly. Birds whose genome is comprised of trangene-derived exogenous antibody-encoding DNA express exogenous antibodies having desirable chemical properties with increased therapeutic utility compared to antibodies derived from bacterial expression systems.
Claims16
A composition comprising monoclonal antibodies encoded by an exogenous polynucleotide and selectively expressed in tubular gland cells of a genetically modified chicken and collected in eggs laid by the chicken, wherein the antibodies are present in egg white at a concentration of at least 40 μg/ml.
A method to produce a monoclonal antibody substantially free of fucosyl residues comprising:
- expressing the antibody in tubular gland cells of a genetically modified chicken having an exogenous polynucleotide incorporated into a genome of the chicken;
- and
- collecting the antibody from eggs laid by the chicken wherein the antibody is present in the egg white at a concentration of at least 40 μg/ml.
A genetically modified chicken expressing in tubular gland cells monoclonal antibodies encoded by an exogenous polynucleotide, wherein the monoclonal antibodies are present in egg white at a concentration of at least 40 μg/ml.
A vector comprising a promoter linked to a heterologous coding sequence to express said coding sequence in tubular gland cells of an avian oviduct.
Dependencies are inferred from the claim text.